应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RTSN Retension Pharmaceuticals
待上市 10-08 16:00:00 EDT
0.0000
+0.0000
--
最高
0.0000
最低
0.0000
成交量
0.00
今开
0.0000
昨收
0.0000
日振幅
0.00%
总市值
0.00
流通市值
0.00
总股本
788.16万
成交额
0.00
换手率
0.00%
流通股本
788.16万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
高血压药物开发商Retension(RTSN.US)IPO定价11-13美元/股 拟筹集4000万美元
智通财经 · 10-06 17:03
高血压药物开发商Retension(RTSN.US)IPO定价11-13美元/股 拟筹集4000万美元
加载更多
公司概况
公司名称:
Retension Pharmaceuticals
所属市场:
NASDAQ
上市日期:
--
主营业务:
Retension Pharmaceuticals, Inc.于2023年7月26日在特拉华州注册成立,总部位于弗吉尼亚州福尔斯彻奇。该公司是一家临床阶段的生物制药公司,专注于开发治疗高血压和其他心血管疾病的药物。其候选产品RTN-001是一种下一代、每日一次的口服小分子PDE-5抑制剂,旨在通过增强一氧化氮信号传导来降低血压,目前正在开发用于未控制的高血压和耐药性高血压患者。
发行价格:
--
{"stockData":{"symbol":"RTSN","market":"US","secType":"STK","nameCN":"Retension Pharmaceuticals","latestPrice":0,"timestamp":1791489600000,"preClose":0,"halted":7,"volume":0,"delay":0,"floatShares":7881600,"shares":7881600,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"10-08 16:00:00 EDT","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":8,"adr":0,"listingDate":1791518400000,"exchange":"NASDAQ","adjPreClose":0,"volumeRatio":0},"requestUrl":"/m/hq/s/RTSN","defaultTab":"news","newsList":[{"id":"2673371790","title":"高血压药物开发商Retension(RTSN.US)IPO定价11-13美元/股 拟筹集4000万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673371790","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673371790?lang=zh_cn&edition=full","pubTime":"2026-10-06 17:03","pubTimestamp":1791277394,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,美国高血压药物开发商Retension Pharmaceuticals周一公布了其首次公开募股条款。该公司计划以每股11至13美元的价格区间发行330万股股票,筹集4000万美元。按发行价区间的中点计算,Retension完全稀释后市值将达到1.08亿美元。Retension成立于2023年,是一家临床阶段生物制药公司,目前专注于开发单一产品RTN-001。Retension计划以“RTSN”为股票代码在纳斯达克上市,Leerink Partners、Guggenheim Securities和 Oppenheimer & Co.担任此次交易的联合承销商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["UDN","RTSN","IPOS","UUP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.retensionpharmaceuticals.com;www.retensionpharma.com","compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0091},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.1439},{"period":"1year","weight":0.1616},{"period":"ytd","weight":0.1398}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Retension Pharmaceuticals, Inc.于2023年7月26日在特拉华州注册成立,总部位于弗吉尼亚州福尔斯彻奇。该公司是一家临床阶段的生物制药公司,专注于开发治疗高血压和其他心血管疾病的药物。其候选产品RTN-001是一种下一代、每日一次的口服小分子PDE-5抑制剂,旨在通过增强一氧化氮信号传导来降低血压,目前正在开发用于未控制的高血压和耐药性高血压患者。","exchange":"NASDAQ","name":"Retension Pharmaceuticals","nameEN":"Retension Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Retension Pharmaceuticals(RTSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Retension Pharmaceuticals(RTSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Retension Pharmaceuticals,RTSN,Retension Pharmaceuticals股票,Retension Pharmaceuticals股票老虎,Retension Pharmaceuticals股票老虎国际,Retension Pharmaceuticals行情,Retension Pharmaceuticals股票行情,Retension Pharmaceuticals股价,Retension Pharmaceuticals股市,Retension Pharmaceuticals股票价格,Retension Pharmaceuticals股票交易,Retension Pharmaceuticals股票购买,Retension Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Retension Pharmaceuticals(RTSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Retension Pharmaceuticals(RTSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}